Pricing Log in Create free account
Saturday 17 October 2026 Export EW’s income statement to Excel — free account

Edwards Lifesciences Corporation

EW Healthcare Medical Devices

Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 13.6%, EPS fell 26.3%, free cash flow grew 142.8% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

86.60 1.50 −1.70%
Market cap
$50.8B
P/E
49.8×
Fwd P/E
30.7×
Dividend yield
—
F-score
5/9
Altman Z
11.54
Beneish M
−2.48
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Edwards Lifesciences Corporation (EW) EBITDA

Alert me on EBITDA

Edwards Lifesciences Corporation's EBITDA for fiscal 2025 was $1.4B, down 7.37% from $1.5B in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.6B. Over the past ten years it has ranged from $708.5M (fiscal 2015) to $1.8B (fiscal 2021); the current reading is higher than 64% of that period. Edwards Lifesciences Corporation ranks 10th of 147 Medical Devices companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $1.4B (7.37%)
FY2024 $1.5B 5.51%
FY2023 $1.5B (11.25%)
FY2022 $1.6B (10.25%)
FY2021 $1.8B 81.64%
FY2020 $1.0B (18.71%)
FY2019 $1.2B 49.72%
FY2018 $825.6M (29.51%)
FY2017 $1.2B 36.99%
FY2016 $855.0M 20.68%

Quarterly newest first

Period EBITDA Change
Jun 2026 $555.9M 7.21%
Mar 2026 $518.5M 167.54%
Dec 2025 $193.8M (44.04%)
Sep 2025 $346.3M (22.92%)
42 more quarters

Against its own ten years

Low $708.5M High $1.8B
Ten-year median $1.2B
Current reading's percentile 64

EBITDA against peers

Company EBITDA
MDT Medtronic PLC compare $9.7B
SYK Stryker Corporation compare $6.8B
BSX Boston Scientific Corporation compare $5.6B
PHG Koninklijke Philips N.V. compare $3.4B
GEHC GE HealthCare Technologies Inc. compare $3.3B
ZBH Zimmer Biomet Holdings, Inc. compare $2.3B
STE STERIS plc compare $1.6B
EW Edwards Lifesciences Corporation $1.6B
DXCM DexCom, Inc. compare $1.4B

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on EW